Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

449 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

NCT00286871

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4

NCT01884402

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Fundación Pública Andaluza para la Gestión de la investigación en salud de Sevilla (FISEVI) Seville, Sevilla, Spain

Fundación Pública Andaluza para la Gestión de la investigación en salud de Sevilla (FISEVI) Seville, Spain

View Trial Details

Completed

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

NCT00323804

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
Locations: CHU Brugmann Brussels, Belgium

Hôpital Bracops Brussels, Belgium

Hôpital Erasme Brussels, Belgium

Hôpital de Jolimont La Louvière, Belgium

View all 45 locations

View Trial Details

Completed

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C

NCT02226939

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection

NCT02226952

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection

NCT00556504

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Completed

Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C

NCT00372385

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Call For Information Call For Information, Austria

Call For Information Call For Information, France

Call For Information Call For Information, Germany

Call for Information Call For Information, United Kingdom

View Trial Details

Completed

Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C

NCT00336479

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Call For Information Phoenix, Arizona, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

Stanford University Liver Research Palo Alto, California, United States

Call For Information San Francisco, California, United States

View all 37 locations

View Trial Details

Completed

Pirfenidone, an Antifibrotic and Antiinflammatory Drug

NCT02161952

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

NCT01581138

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +15 more
Locations: Birmingham, Alabama, United States

Anaheim, California, United States

Riverside, California, United States

San Diego, California, United States

View all 18 locations

View Trial Details